Shanghai Henlius Biotech Company

Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services. The company focuses on the development, production and commercialization of mAb biosimilar drugs, bio-betters, and novel mAbs using cutting-edge technology.
Industry: Genomic and Epigenominc Instabillity
Headquarters: China

Visit Website
Register and Claim Ownership